Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 25,367 | 27,666 | 25,119 | 27,021 | 25,646 |
| Cost of Goods | 14,213 | 14,064 | 12,838 | 15,854 | 16,426 |
| Gross Profit | 11,154 | 13,602 | 12,281 | 11,167 | 9,220 |
| Operating Expenses | 32,539 | 31,115 | 29,712 | 33,133 | 38,673 |
| Operating Income | -21,172 | -17,449 | -16,593 | -21,112 | -29,027 |
| Interest Expense | 0 | 0 | 0 | 1,190 | 1,049 |
| Other Income | 225 | 710 | 13 | 1,527 | -63 |
| Pre-tax Income | -20,947 | -16,739 | -16,580 | -20,775 | -30,139 |
| Income Tax | 50 | 301 | 263 | 70 | -713 |
| Net Income Continuous | -20,997 | -17,040 | -16,843 | -20,845 | -29,426 |
| Net Income | $-20,997 | $-17,040 | $-16,843 | $-20,845 | $-29,426 |
| EPS Basic Total Ops | -0.27 | -0.22 | -0.21 | -0.25 | -0.37 |
| EPS Basic Continuous Ops | -0.27 | -0.22 | -0.21 | -0.25 | -0.37 |
| EPS Diluted Total Ops | -0.27 | -0.22 | -0.21 | -0.25 | -0.37 |
| EPS Diluted Continuous Ops | -0.27 | -0.22 | -0.21 | -0.25 | -0.37 |
| EBITDA(a) | $-17,356 | $-13,809 | $-13,096 | $-18,795 | $-25,220 |